Status:

TERMINATED

Evaluation of cCeLL-Ex Vivo Confocal Microscopy for Real-time Brain Tumor Diagnosis

Lead Sponsor:

VPIX Medical

Collaborating Sponsors:

Unity Health Toronto

Korea University Anam Hospital

Conditions:

Benign Brain Tumor

Malignant Brain Tumor

Eligibility:

All Genders

19+ years

Phase:

NA

Brief Summary

Intra-operative evaluation of residual brain tumor currently relies on frozen-section histopathology, which typically requires 20-30 minutes for tissue processing and interpretation, prolonging operat...

Detailed Description

Primary Objective Demonstrate non-inferiority of cCeLL - Ex vivo versus frozen-section histopathology in terms of clinical sensitivity and specificity for intra-operative brain-tumor diagnosis. Seco...

Eligibility Criteria

Inclusion

  • Inclusion Criteria
  • Specimens and images used in this study must meet all of the following criteria:
  • Tissue obtained from male or female patients aged 19 years or older.
  • Tissue collected from patients scheduled for neurosurgical resection of a suspected brain tumor.
  • Tissue obtained from patients capable of understanding and signing the informed consent form.
  • Exclusion Criteria
  • Specimens and images that meet any of the following criteria will be excluded from the study:
  • Emergency cases where informed consent could not be obtained before surgery.
  • Specimens with significant hemorrhage, affecting image quality.
  • Small biopsy specimens that do not meet the required size for imaging.
  • Poor-quality images that do not meet study criteria, including:
  • Low-quality cCeLL - Ex vivo images.
  • Non-diagnostic cCeLL - Ex vivo images of the tumor core.
  • Cases deemed inappropriate for the study by the principal investigator or study staff due to ethical concerns or potential impact on study results.
  • Patients undergoing multiple surgeries at the same site.

Exclusion

    Key Trial Info

    Start Date :

    January 1 2023

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    November 27 2024

    Estimated Enrollment :

    285 Patients enrolled

    Trial Details

    Trial ID

    NCT06098248

    Start Date

    January 1 2023

    End Date

    November 27 2024

    Last Update

    December 15 2025

    Active Locations (4)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (4 locations)

    1

    St. Michael's Hospital

    Toronto, Ontario, Canada, M5B 1W8

    2

    Korea University Anam Hospital

    Seoul, South Korea

    3

    Samsung Medical Center

    Seoul, South Korea

    4

    Seoul National University Hospital

    Seoul, South Korea